News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avrobio Inc
(NQ:
AVRO
)
1.400
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Avrobio Inc
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 09, 2022
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 13.6% to $1.25 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1...
Via
Benzinga
AVROBIO Reports Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis
February 09, 2022
From
AVROBIO, Inc.
Via
Business Wire
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, & More
February 06, 2022
Biotech stocks managed to close the week with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid some big pharma earnings. The sector came...
Via
Talk Markets
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 04, 2022
From
AVROBIO, Inc.
Via
Business Wire
Analyst Ratings For Avrobio
January 05, 2022
Within the last quarter, Avrobio (NASDAQ:AVRO) has observed the following a...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
AVROBIO Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer
February 01, 2022
From
AVROBIO, Inc.
Via
Business Wire
Why Avrobio's Shares Are Plunging Today
January 04, 2022
Avrobio Inc (NASDAQ: AVRO) has updated its pipeline deprioritizing its Fabry disease clinical program to focus on other clinical-stage studies in the lysosomal...
Via
Benzinga
AVROBIO to Present at Cowen’s 2nd Annual Genetic Medicines Summit
January 28, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present New Data from Phase 1/2 Clinical Trial in Cystinosis at WORLDSymposium™ 2022
January 27, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 06, 2022
From
AVROBIO, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Upgrades According to TD Securities, the prior rating for Canada Goose Holdings Inc (NYSE:
Via
Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide
January 04, 2022
Toward the end of trading Tuesday, the Dow traded up 0.70% to 36,839.62 while the NASDAQ fell 1.57% to 15,583.77. The S&P also fell, dropping 0.03% to 4,794.93. The U.S. has...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 04, 2022
Gainers Hoth Therapeutics (NASDAQ:
Via
Benzinga
Dow, S&P 500 Nab Intraday Highs as Bond Yields Rise
January 04, 2022
The Dow Jones Industrial Average is up 242 points midday, pacing for another record close. The S&P 500 Index also hit an intraday record this morning but has since joined the tech-heavy Nasdaq...
Via
Talk Markets
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
January 04, 2022
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the...
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
January 04, 2022
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Higher; ISM Manufacturing Index Drops To 58.7
January 04, 2022
Following the market opening Tuesday, the Dow traded up 0.74% to 36,857.55 while the NASDAQ fell 0.14% to 15,811.30. The S&P also rose, gaining 0.40% to 4,815.75. The U.S. has...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 04, 2022
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $28....
Via
Benzinga
AVROBIO Reprioritizes Pipeline Programs
January 04, 2022
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 07, 2021
From
AVROBIO, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
November 26, 2021
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 115.09% to $21.94 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 62.8...
Via
Benzinga
AVROBIO Presents Clinician Experience with FAB-GT Clinical Trial and Updated Safety Data for Investigational Gene Therapies in Fabry Disease and Gaucher Disease Type 1
November 24, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO to Present at Two Upcoming Investor Conferences in November
November 09, 2021
From
AVROBIO, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
Upgrades Morgan Stanley upgraded the previous rating for EQT Corp (NYSE:
Via
Benzinga
AVROBIO to Present Clinical and Preclinical Data at the 14th ICIEM Conference
November 08, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 05, 2021
From
AVROBIO, Inc.
Via
Business Wire
AVROBIO Reports Third Quarter 2021 Financial Results and Provides Business Update
November 04, 2021
From
AVROBIO, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.